Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease
Peter K Wong, Gelsomina L Borromeo, John D Wark
RHEUMATOLOGY INTERNATIONAL | SPRINGER HEIDELBERG | Published : 2013
PKKW has received speaking honoraria, travel support or unrestricted research grants from Amgen, Eli Lilly, Sanofi-Aventis, Novartis and Servier. JDW has received speaking honoraria, travel support or unrestricted research grants from Amgen, Eli Lilly, GSK, Merck Sharpe and Dohme, Novartis, Sanofi-Aventis and Servier. He has served on advisory boards for Amgen/GSK and Novartis. Specifically, Novartis has provided an unrestricted grant to the authors to conduct a case-control study of delayed dental healing in patients on BPs. GB has no other competing interests.